Alvotech

STU:Z45 (Luxembourg)  
€ 13.35 (-2.55%) May 3
At Loss
Market Cap:
€ 3.75B ($ 4.04B)
Enterprise V:
€ 4.74B ($ 5.11B)
Volume:
375.00
Avg Vol (2M):
575.00
Also Trade In:

Business Description

Description
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 0.01
Equity-to-Asset -0.98
Debt-to-Equity -1.15
Debt-to-EBITDA -2.18
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -3.75
Distress
Grey
Safe
Beneish M-Score -3.25
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 66.98
9-Day RSI 66.53
14-Day RSI 61
6-1 Month Momentum % 31.25
12-1 Month Momentum % 14.88

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.75
Quick Ratio 0.46
Cash Ratio 0.04
Days Inventory 173.59
Days Sales Outstanding 113.8
Days Payable 116.23

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -3.1
Shareholder Yield % -9.6
Name Current Vs Industry Vs History
Gross Margin % -75.93
Operating Margin % -388.11
Net Margin % -603.42
FCF Margin % -394.64
ROA % -60.72
ROIC % -37.97
ROC (Joel Greenblatt) % -164.01
ROCE % -73.01

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 39.24
EV-to-EBIT -9.83
EV-to-EBITDA -10.31
EV-to-Revenue 55.67
EV-to-FCF -14.19
Earnings Yield (Greenblatt) % -10.17
FCF Yield % -8.91

Financials (Next Earnings Date:2024-05-17 Est.)

STU:Z45's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Alvotech Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 84.497
EPS (TTM) (€) -2.26
Beta 0
Volatility % 60.24
14-Day RSI 61
14-Day ATR (€) 0.341753
20-Day SMA (€) 12.0725
12-1 Month Momentum % 14.88
52-Week Range (€) 6.28 - 16.75
Shares Outstanding (Mil) 279.57

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Alvotech Filings

Filing Date Document Date Form
No Filing Data

Alvotech Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Alvotech Frequently Asked Questions

What is Alvotech(STU:Z45)'s stock price today?
The current price of STU:Z45 is €13.35. The 52 week high of STU:Z45 is €16.75 and 52 week low is €6.28.
When is next earnings date of Alvotech(STU:Z45)?
The next earnings date of Alvotech(STU:Z45) is 2024-05-17 Est..
Does Alvotech(STU:Z45) pay dividends? If so, how much?
Alvotech(STU:Z45) does not pay dividend.

Press Release

Subject Date
No Press Release